Potential in the Colombian medical device market
Medical devices are one of the most profitable niches in Colombian health. Marisol Sanchez, president of the Camara de Proveedores de Salud, notes that “the medical device sector correlated to…
Address: Calle 20 A # 44 – 70 Bogotá D.C.,Colombia
Tel: (571) 368 0077
Genfar S.A., a Multi-Latin company; legitimately Colombian, was established in August 18, 1967. It counts upon a pharmaceutical complex which is considered to be one of the most thorough and modern facilities throughout Latin America, due to his OUTSTANDING HUMAN TALENT AND TECHNOLOGY in all of its production processes; having corporate headquarters in Bogota, Colombia, subsidiaries in Peru and Ecuador, and dealers throughout Central and South America.
Genfar S.A., the pharmaceutical market leader nation wise; for more than 38 years has been committed to the manufacturing and production of generic, over the count, and under prescription drugs for both Human and Animal Health Division; which demonstrate a DEVELOPMENTAL AND INNOVATIVE process which has made a remarkable distinction over the quality of our products from the very first day.
It has kept its commitment over time to verify and guaranty the quality of its products, outstanding service, and its purpose for delivering to human kind, that which is most precious; the means to preserve both health and life.
We are a transparent, ethical, dynamic, flexible, solidary, and benevolent company with a sense of environmental and social responsibility, dedicated to developing, manufacturing, and marketing drugs and products characterized by their quality, effectiveness, innovation, and economy, devoted to the national and international markets.
We rely on state entities; providers; advanced technology and great HUMAN RESOURCES, oriented towards excellence in the service and satisfaction of health necessities and/or well-being of our consumers, customers in general, and health professionals.
We are committed to the development of our contributors and their families; assuring our share holders the highest satisfaction and profitability.
OTC PRODUCT LINE
Acetaminophen
Calcium
Calcium + Vitamin D
Calprax®
Clotrimazole Topical Cream
Diclofenaco Emulsion – Gel
genfargrip
Ibuprofen
Iodine Povidone
Isoconazole
Ketoprofen Gel
Piroxicam gel
terbinafina
Vitamin C
MEDICAL PRESCRIPTION PRODUCTS
Aciclovir
Aciclovir cream
Aciclovir Ointment
Albendazole
Alendronate
Ambroxole
Amlodipine
Amoxicillin
Ampicillin
Atorvastatine
Azytromicine
Betamethasone
Betamethasone + clotrimazole + neomicine
Betamethasone injectable
Buspirone
Candesartan
Captoprile
Carbamazepine
Cefadroxil
cefalotina
Cefotaxime
Ceftazidime
Ceftriaxone
Cefuroxime
Celecoxib
Cephalexin
Cephazoline
Cephradine
Cetirizine
Ciprofloxacine
Clarithromycin
Clindamycin
Clotrimazole
Crotamiton
Diclofenac
Dicloxacillin
Diltiazem
Dinak
Enalapril
Erithromicin
Esomeprazol
Flubendazole
Fluconazole
Flunarizin
Fluoxetin
Furosemide
Fusidic Acid
Gemfibrozile
Genfargrip
Gentamicin
Ginkgo Biloba
Gleminex
Glucinex
Hydrochlorothiazide
Hydroxicine
Ibuprofen + Metocarbamole
Isosorbide Mononitrate
Ivermectin
ketoconazole
ketoconazole Cream
Ketoprofen
Ketorolac
Ketotifen
Lansoprazole
Levofloxacine
Lincomycin
Loratadine
Losartan
Lovastatin
Mebendazole
Metgluk
Metoclopramide
Metronidazole
Mometasone
Montelukast
Naproxene
Nifedipine
Norfloxacine
Omeprazole
Penicillin G Benzathine
Penicillin G Procaine
Penicillin G Procaine + Penicillin G Sodium
Penicillin G Sodium
Pentoxifylline
Piracetam
Piroxicam
Pravastatin
Propranolol
Pyrantel Pamoate
Ranitidine
Salbutamole
Secnidazole
Sertraline
Sibutramine
SIDELG
sildenafil
silimarine
Silver sulfadiazine
simvastatin
Sumatriptan
Tenoxicam
Teophylline Retard
Terbinafina
Tetracycline
Thiamine
Tinidazole
Tramadol
Trimebutine
Trimethoprim Sulfa
Trimethoprim Sulfa F
Tyclopidine
Valsartan
VALSARTÁN + HIDROCLOROTIAZIDA Genfar®
Verapamil
Vitamin B Complex
Xilbac
zolpidem
Zopiclone
Medical devices are one of the most profitable niches in Colombian health. Marisol Sanchez, president of the Camara de Proveedores de Salud, notes that “the medical device sector correlated to…
President Santos appointed economist Alejandro Gaviria as the new Minister of Health and Social Protection in September 2012. Gaviria’s priority has been to create health reform that would introduce…
Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. Thanks to the ratification of free trade agreements with 14 countries around the…
Carlos Manuel González Parra discusses the progress Novo Nordisk has made as a newcomer to the Colombian market and its hopes and intentions for the future. One of the main…
Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The…
As a means of introduction, could you describe your background and how you became involved with Nutripharma in the first place? Nutripharma is a 12-year-old family company created by my…
Can you trace the evolution of the Colombian economy over the last few years? The Colombian economy is experiencing a time of significant growth with production and investment projects as…
Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you…
What is your background, and how did you become involved with Grupo Amarey? My first job in the medical industry was with Johnson & Johnson Medical, which back then was…
In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments…
The operations and sales managers of Cegedim Colombia discuss the impact of healthcare reform on the Colombian pharma market, partnering opportunities in the…
You have an extensive background in the healthcare sector, with positions in Colciencias, the Department of Public Health, and the National University of Colombia. What can you bring from these…
See our Cookie Privacy Policy Here
